Study of ATH434 in Participants With Multiple System Atrophy

Status:
Not yet recruiting

Trial end date:
2023-11-01

Target enrollment:

Participant gender:

This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy

Phase 2

Alterity Therapeutics